相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Post-treatment control or treated controllers? Viral remission in treated and untreated primary HIV infection
Genevieve E. Martin et al.
AIDS (2017)
The size of the expressed HIV reservoir predicts timing of viral rebound after treatment interruption
Jonathan Z. Li et al.
AIDS (2016)
The Safety and Immunogenicity of an Interleukin-12-Enhanced Multiantigen DNA Vaccine Delivered by Electroporation for the Treatment of HIV-1 Infection
Jeffrey M. Jacobson et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2016)
Dendritic Cell Immunotherapy for HIV-1 Infection Using Autologous HIV-1 RNA: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Jeffrey M. Jacobson et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2016)
Therapeutic vaccines and immunological intervention in HIV infection: a paradigm change
Giuseppe Pantaleo et al.
CURRENT OPINION IN HIV AND AIDS (2016)
No evidence of posttreatment control after early initiation of antiretroviral therapy
Sara Gianella et al.
AIDS (2015)
HIV reservoirs as obstacles and opportunities for an HIV cure
Tae-Wook Chun et al.
NATURE IMMUNOLOGY (2015)
First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Vesicular Stomatitis Virus Human Immunodeficiency Virus-1 gag Vaccine (HVTN 090)
Jonathan D. Fuchs et al.
OPEN FORUM INFECTIOUS DISEASES (2015)
Dendritic cell-based therapeutic vaccine elicits polyfunctional HIV-specific T-cell immunity associated with control of viral load
Yves Levy et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2014)
Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4x: a phase 2 randomised, double-blind, placebo-controlled trial
Richard B. Pollard et al.
LANCET INFECTIOUS DISEASES (2014)
Immune Activation with HIV Vaccines
Anthony S. Fauci et al.
SCIENCE (2014)
HIV Incidence Determination in the United States: A Multiassay Approach
Oliver Laeyendecker et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Short-Course Antiretroviral Therapy in Primary HIV Infection
Sarah Fidler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
A Dendritic Cell-Based Vaccine Elicits T Cell Responses Associated with Control of HIV-1 Replication
Felipe Garcia et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study
Asier Saez-Cirion et al.
PLOS PATHOGENS (2013)
HIV-1 control after transient antiretroviral treatment initiated in primary infection: role of patient characteristics and effect of therapy
Cecile Goujard et al.
ANTIVIRAL THERAPY (2012)
Immunovirologic Control 24 Months After Interruption of Antiretroviral Therapy Initiated Close to HIV Seroconversion
Sara Lodi et al.
ARCHIVES OF INTERNAL MEDICINE (2012)
OMIP-014: Validated multifunctional characterization of antigen-specific human T cells by intracellular cytokine staining
Stephen C. De Rosa et al.
CYTOMETRY PART A (2012)
HIV-1 Tat B-cell epitope vaccination was ineffectual in preventing viral rebound after ART cessation HIV rebound with current ART appears to be due to infection with new endogenous founder virus and not to resurgence of pre-existing Tat-dependent viremia
Gideon Goldstein et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2012)
No Treatment versus 24 or 60 Weeks of Antiretroviral Treatment during Primary HIV Infection: The Randomized Primo-SHM Trial
Marlous L. Grijsen et al.
PLOS MEDICINE (2012)
A randomized controlled trial of HIV therapeutic vaccination using ALVAC with or without Remune
Jonathan B. Angel et al.
AIDS (2011)
Long-term Nonprogressive Disease Among Untreated HIV-Infected Individuals Clinical Implications of Understanding Immune Control of HIV
Stephen A. Migueles et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
AIDS Clinical Trials Group 5197: A Placebo-Controlled Trial of Immunization of HIV-1-Infected Persons with a Replication-Deficient Adenovirus Type 5 Vaccine Expressing the HIV-1 Core Protein
Robert T. Schooley et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Antiretroviral therapy and management of HIV infection
Paul A. Volberding et al.
LANCET (2010)
Safety and Immunogenicity of Therapeutic DNA Vaccination in Individuals Treated with Antiretroviral Therapy during Acute/Early HIV-1 Infection
Eric S. Rosenberg et al.
PLOS ONE (2010)
Combined effects of IL-12 and electroporation enhances the potency of DNA vaccination in macaques
Lauren A. Hirao et al.
VACCINE (2008)
Interruption of antiretroviral therapy initiated during primary HIV-1 infection:: Impact of a therapeutic vaccination strategy combined with interleukin (IL)-2 compared with IL-2 alone in the ANRS 095 randomized study
Cecile Goujard et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2007)
Optimization and validation of an 8-color intracellular cytokine staining (ICS) assay to quantify antigen-specific T cells induced by vaccination
Helen Horton et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2007)
Effect of plasmid DNA vaccine design and in vivo electroporation on the resulting vaccine-specific immune responses in rhesus macaques
Amara Luckay et al.
JOURNAL OF VIROLOGY (2007)
Peptide selection for human immunodeficiency virus type 1 CTL-based vaccine evaluation
Fusheng Li et al.
VACCINE (2006)
Amine reactive dyes: An effective tool to discriminate live and dead cells in polychromatic flow cytometry
Stephen P. Perfetto et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2006)
Longitudinal analysis of clinical markers following antiretroviral therapy initiated during acute or early HIV type 1 infection
S Kassutto et al.
CLINICAL INFECTIOUS DISEASES (2006)
分享论文
